tradingkey.logo
tradingkey.logo
Search

Outset Medical Inc

OM
Add to Watchlist
3.630USD
-0.180-4.72%
Close 05/15, 16:00ETQuotes delayed by 15 min
67.26MMarket Cap
LossP/E TTM

Outset Medical Inc

3.630
-0.180-4.72%

More Details of Outset Medical Inc Company

Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Outset Medical Inc Info

Ticker SymbolOM
Company nameOutset Medical Inc
IPO dateSep 15, 2020
CEOTrigg (Leslie L)
Number of employees354
Security typeOrdinary Share
Fiscal year-endSep 15
Address3052 Orchard Drive
CitySAN JOSE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code95134
Phone16692318200
Websitehttps://outsetmedical.com/
Ticker SymbolOM
IPO dateSep 15, 2020
CEOTrigg (Leslie L)

Company Executives of Outset Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
211.19K
+89.13%
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.06K
+54.85%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
23.13K
+55.67%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
19.26K
-66.63%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
3.75K
-104.77%
Mr. D. Keith Grossman
Mr. D. Keith Grossman
Lead Independent Director
Lead Independent Director
--
--
Ms. Andrea L. Saia
Ms. Andrea L. Saia
Independent Director
Independent Director
--
--
Mr. John L. Brottem
Mr. John L. Brottem
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Kevin O'Boyle
Mr. Kevin O'Boyle
Independent Director
Independent Director
--
--
Ms. Renee M. Gaeta, CPA
Ms. Renee M. Gaeta, CPA
Chief Financial Officer
Chief Financial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
211.19K
+89.13%
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.06K
+54.85%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
23.13K
+55.67%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
19.26K
-66.63%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
3.75K
-104.77%
Mr. D. Keith Grossman
Mr. D. Keith Grossman
Lead Independent Director
Lead Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Consumables
54.08M
45.26%
Services and other revenue
34.67M
29.02%
Consoles
30.73M
25.72%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
54.08M
45.26%
Services and other revenue
34.67M
29.02%
Consoles
30.73M
25.72%

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.25%
BML Capital Management LLC
10.26%
Alyeska Investment Group, L.P.
8.71%
Woodline Partners LP
7.15%
BlackRock Institutional Trust Company, N.A.
6.20%
Other
53.43%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.25%
BML Capital Management LLC
10.26%
Alyeska Investment Group, L.P.
8.71%
Woodline Partners LP
7.15%
BlackRock Institutional Trust Company, N.A.
6.20%
Other
53.43%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.07%
Hedge Fund
20.78%
Investment Advisor/Hedge Fund
11.40%
Research Firm
6.36%
Private Equity
4.50%
Individual Investor
3.02%
Venture Capital
1.18%
Corporation
0.60%
Bank and Trust
0.44%
Other
3.66%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
271
18.17M
98.04%
-3.19M
2025Q4
273
18.05M
99.45%
-1.75M
2025Q3
319
18.96M
106.72%
+1.93M
2025Q2
348
16.26M
91.74%
+11.98M
2025Q1
363
14.91M
84.25%
+11.40M
2024Q4
375
22.97M
42.67%
-34.22M
2024Q3
383
28.58M
54.40%
-41.22M
2024Q2
397
50.60M
97.17%
-19.65M
2024Q1
406
52.26M
101.52%
-18.15M
2023Q4
416
54.21M
107.73%
-7.17M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
2.64M
14.42%
+6.40K
+0.24%
Dec 31, 2025
BML Capital Management LLC
1.90M
10.39%
+196.32K
+11.51%
Feb 12, 2026
Alyeska Investment Group, L.P.
1.61M
8.82%
--
--
Dec 31, 2025
Woodline Partners LP
1.33M
7.24%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.15M
6.27%
+26.81K
+2.39%
Dec 31, 2025
BofA Global Research (US)
950.54K
5.19%
+927.49K
+4023.66%
Dec 31, 2025
Perceptive Advisors LLC
833.33K
4.55%
--
--
Dec 31, 2025
Ensign Peak Advisors, Inc.
560.17K
3.06%
+234.08K
+71.79%
Dec 31, 2025
PFM Health Sciences, LP
530.80K
2.9%
-1.20M
-69.32%
Dec 31, 2025
View more

Related ETFs

Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Date
Ex-dividend Date
Type
Ratio
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
KeyAI